Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement GMPs Reach “Final Stages Of Getting Finalized,” Crawford Says

This article was originally published in The Tan Sheet

Executive Summary

If dietary supplement good manufacturing practices are not "done by the end of this year, as many times as I've said that, then I think probably I'm going to have to go back to the Center for Veterinary Medicine," Lester Crawford joked during one of his first public speeches since being confirmed FDA Commissioner

You may also be interested in...



FDA Accomplishes A-List Goals, Will Publish NDI Guidance – CFSAN

FDA will publish guidance documents on new dietary ingredient submissions as part of an effort to update the industry on its premarket notification program, CFSAN announced in an Aug. 18 conference call on its program priorities

FDA Accomplishes A-List Goals, Will Publish NDI Guidance – CFSAN

FDA will publish guidance documents on new dietary ingredient submissions as part of an effort to update the industry on its premarket notification program, CFSAN announced in an Aug. 18 conference call on its program priorities

FDA Accomplishes A-List Goals, Will Publish NDI Guidance – CFSAN

FDA will publish guidance documents on new dietary ingredient submissions as part of an effort to update the industry on its premarket notification program, CFSAN announced in an Aug. 18 conference call on its program priorities

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel